Technology
Transforming the treatment of structural heart disease
SEPTAL MYOTOMY
Pioneering a widely accessible interventional solution for hypertrophic cardiomyopathy patients
Limited accessible treatment options are currently available for patients with hypertrophic cardiomyopathy where a thickened septum partially blocks the outflow tract and obstructs blood flow from the left ventricle to the aorta.
Excision Myotomy Solution
Transfemoral access
Leverages proven efficacy of lacerating hypertrophied septum
Purpose-built to orient, secure, & control laceration for fast repeatable procedure
Warning: Excision Medical is a development stage company and the Myotomy solution is not approved by the FDA.
LEAFLET MODIFICATION
Pioneering a widely accessible interventional solution for aortic leaflet modification
Many patients who are candidates for transcatheter aortic valve replacement (TAVR), for both native aortic stenosis and replacement of a prior bioprosthetic valve, are at risk for coronary obstruction or compromised coronary access.
Excision Leaflet Modification Solution
Transfemoral access
RF-enabled to control cut and help minimize procedural risks
Low profile
Efficient
Warning: Excision Medical is a development stage company and the Leaflet Modification solution is not approved by the FDA.